Pickens v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided October 17, 2019·No. 17-187·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS

********************* DENNIS PICKENS, * * No. 17-187V * Special Master Christian J. Moran Petitioner, * v. * * Filed: September 20, 2019 SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Attorneys’ fees and costs, interim Respondent. * award *********************

Andrew D. Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for Petitioner; Darryl R. Wishard, United States Dep’t of Justice, Washington, D.C., for Respondent.

UNPUBLISHED DECISION AWARDING ATTORNEYS’ FEES AND COSTS ON AN INTERIM BASIS1

On February 8, 2017, Dennis Pickens (“Petitioner”) filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa–10 through 34 (2012). Petitioner claims that he suffered from chronic inflammatory demyelinating polyneuropathy (“CIDP”) after receiving a measles-mumps-rubella (“MMR”) vaccine on February 9, 2015. Pet., filed Feb. 8, 2017, at 1. Petitioner’s counsel of record is Mr. Andrew Downing.

On July 4, 2017, the Secretary argued that compensation was not appropriate because petitioner’s progression of symptoms better supported a diagnosis of

1 The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services), requires that the Court post this decision on its website. This posting will make the decision available to anyone with the internet. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special master will appear in the document posted on the website. Guillain-Barré syndrome than CIDP. Resp’t’s Rep. at 11–12. The Secretary also argued that, regardless of his diagnosis, none of petitioner’s treating physicians attributed his condition to the MMR vaccine, petitioner did not offer an expert report in support of his claim, and, at 73 days post vaccination, the onset of petitioner’s symptoms was outside the medically accepted period for CIDP. Id. at 12–13.

To develop his case, petitioner filed an expert report from Dr. Robert J. Friedman, a specialist in neurology, pain medicine, and neuromuscular medicine. Exhibit 23. In rebuttal, the Secretary filed an expert report from Dr. Peter D. Donofrio, a neurologist. Exhibit A.

A fact hearing was held on June 11, 2019, when petitioner and three witnesses testified. Following the hearing, petitioner filed additional medical records, which completed the evidentiary record on the issue of petitioner’s neurological symptoms. See Order, issued July 17, 2019.

On July 15, 2019, petitioner moved for an award of attorneys’ fees and costs on an interim basis, requesting $53,371.00 in fees and $16,664.73 in costs, for a total of $70,035.73. Pet’r’s Mot. IAFC at 2, 4. For the reasons that follow, petitioner is awarded $56,238.28.

* * *

The requested fees include work performed and costs incurred through July 15, 2019. Id., Exhibit A at 36. Petitioner argues that an award of interim fees and costs is appropriate in this case because the proceedings have been ongoing for “nearly two-and-a-half years without reimbursement to [p]etitioner for time and expenses.” Pet’r’s Mot. IAFC at 2.

The Secretary filed his response to petitioner’s motion on July 17, 2019. Resp’t’s Resp. The Secretary did not provide any objection to petitioner’s request. Id. at 2. Instead, he stated that he “defers to the Special Master to determine whether or not petitioner has met the legal standard for an interim fees and costs award. Id. The Secretary noted, however, that he “is satisfied that the statutory and other legal requirements for an award of attorneys’ fees and costs are met” in the instant case. Id.

2 This matter is now ripe for adjudication.

Petitioner’s motion implicitly raises a series of sequential questions, each of which requires an affirmative answer to the previous question. First, whether petitioner is eligible under the Vaccine Act to receive an award of attorneys’ fees and costs? Second, whether, as a matter of discretion, petitioner should be awarded his attorneys’ fees and costs on an interim basis? Third, what is a reasonable amount of attorneys’ fees and costs? These questions are addressed below.

1. Eligibility for an Award of Attorneys’ Fees and Costs

As an initial matter, interim fee awards are available in Vaccine Act cases. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008). Since petitioner has not received compensation from the Program, he may be awarded “compensation to cover [his] reasonable attorneys’ fees and other costs incurred in any proceeding on such petition if the special master or court determines that the petition was brought in good faith and there was a reasonable basis for the claim.” 42 U.S.C. § 300aa-15(e)(1). As the Federal Circuit has stated, “good faith” and “reasonable basis” are two separate elements that must be met for a petitioner to be eligible for attorneys’ fees and costs. Simmons v. Sec’y of Health & Human Servs., 875 F.3d 632, 635 (Fed. Cir. 2017).

“Good faith” is a subjective standard. Id.; Hamrick v. Sec’y of Health & Human Servs., No. 99-683V, 2007 WL 4793152, at *3 (Fed. Cl. Spec. Mstr. Nov. 19, 2007). A petitioner acts in “good faith” if he or she honestly believes that a vaccine injury occurred. Turner v. Sec’y of Health & Human Servs., No. 99-544V, 2007 WL 4410030, at * 5 (Fed. Cl. Spec. Mstr. Nov. 30, 2007). The Secretary has not challenged petitioner’s good faith here, and there is little doubt that petitioner brought the claim with an honest belief that a vaccine injury occurred.

In contrast to good faith, reasonable basis is purely an objective evaluation of the weight of the evidence. Simmons, 875 F.3d at 636. Because evidence is “objective,” the Federal Circuit’s description is consistent with viewing the reasonable basis standard as creating a test that petitioners meet by submitting

3 evidence. See Chuisano v. Secʼy of Health & Human Servs., No. 07-452V, 2013 WL 6234660 at *12–13 (Fed. Cl. Spec. Mstr. Oct. 25, 2013) (explaining that reasonable basis is met with evidence), mot. for rev. denied, 116 Fed. Cl. 276 (2014).

Here, the report from the expert petitioner has retained, Dr. Friedman, together with testimony given by petitioner and three witnesses at the fact hearing, satisfy the reasonable basis standard. See Pet’r’s Exhibit 23. In his ten-page report, Dr. Friedman summarized the pertinent medical facts, explained why petitioner’s diagnosis of CIDP is more appropriate than GBS, and proposed a causation theory linking the MMR vaccine with petitioner’s injury. See id. In addition, petitioner and his three witnesses gave extensive testimony on the hearing date. See Tr. 11:12–167:4, 169:12–196:19, 198:2–213:7, 213:23–249:6.

2. Appropriateness of an Interim Award

Interim awards should not be awarded as a matter of right. Avera, 515 F.3d at 1352 (Fed. Cir. 2008). Instead, petitioners must demonstrate “undue hardship.” Id. The Federal Circuit noted that interim fees “are particularly appropriate in cases where proceedings are protracted and costly experts must be retained.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Pickens v. Secretary of Health and Human Services, (uscfc 2019).

Pickens v. Secretary of Health and Human Services (Pickens v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related